+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Fertility Services Market by Procedure and Service: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 4989435
  • Report
  • October 2019
  • Region: Global
  • 206 pages
  • Allied Analytics LLP
UP TO OFF
until May 30th 2020
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Medicover Group
  • Monash IVF Group
  • OvaScience Inc.
  • Progyny Inc.
  • Xytex Cryo Internationa
  • MORE
The global fertility services market generated $13,655 million in 2018 and is projected to reach $27,151 million by 2026, growing at a CAGR of 8.9% from 2019 to 2026 Fertility services are services availed by people who are unable to conceive naturally. These services help infertile couples, single parents, and LGBT community to procreate and start a family. In vitro fertilization and other assisted reproductive technology (ART) procedures, surrogacy, and artificial insemination are some of the widely executed fertility services.

The fertility service market is anticipated to grow considerably in the near future owing to different factors such as an an increase in infertility rates, changes in lifestyle, and a a surge in the incidence of male infertility cases. Low awareness with respect to fertility services in emerging markets restricts market growth. The rise in the prevalence due to an an increase in risk factors, such as obesity, stress, polycystic ovarian syndrome (PCOS), sexually transmitted infections, endometrial tuberculosis, and other medical conditions, is expected to offer lucrative opportunities for market growth during the forecast period.

In the procedures segment, fertility clinics accounted for around 50% of the market share of the global fertility services market in 2018. In terms of services, egg & embryo banking segment is anticipated to grow at the fastest growth rate of 11.2% during the forecast period. This segment would exhibit a prominent growth rate owing to its crucial role in preservation of embryos, which is one of the essential factors for a successful assisted reproductive technology procedure. In addition, the segment of surgical centers would exhibit prominent growth rate due to availability of various fertility procedures under one roof, development of fertility devices with advanced technologies, and the availability of a skilled workforce. By region, Asia-Pacific generated the highest revenue in the global fertility services market in 2018.

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS

By Procedure
  • IVF with ICSI
  • IUI
  • IVF without ICSI
  • Surrogacy
  • Others
By Service
  • Fresh Non-donor
  • Frozen Non-donor
  • Egg & Embryo Banking
  • Fresh Donor
  • Frozen Donor
By End User
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes
By Region

North America
  • U.S.
  • Canada
  • Mexico
Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe
Asia-Pacific
  • Japan
  • India
  • China
  • Australia
  • South Korea
  • Rest of Asia-Pacific
LAMEA
  • Latin America
  • Middle East
  • Africa
LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Apollo Hospitals Enterprise Ltd
  • Care Fertility Group Ltd
  • Carolinas Fertility Institute
  • City Fertility
  • Fertility Associates Limited
  • Genea Limited
  • Medicover Group
  • Monash IVF Group Limited
  • Progyny Inc.
  • Virtus Health
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Medicover Group
  • Monash IVF Group
  • OvaScience Inc.
  • Progyny Inc.
  • Xytex Cryo Internationa
  • MORE
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools & Models

Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective

Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter’S Five Force Analysis
3.4. Government Regulations
3.4.1. U.S.
3.4.2. Europe
3.5. Insurance Reimbursement Scenario
3.6. Market Dynamics
3.6.1. Drivers
3.6.1.1. Continuous Decline In Fertility Rates
3.6.1.2. Delayed Pregnancies In Women
3.6.1.3. Technological Advancements With Respect To Fertility Treatment
3.6.2. Restraints
3.6.2.1. High Treatment Costs of Arts In Developed Countries
3.6.2.2. Inadequate Reimbursement Policies
3.6.3. Opportunity
3.6.3.1. Rise In Fertility Tourism

Chapter 4: Fertility Services Market, By Procedure
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Ivf With Icsi
4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast
4.3. Iui
4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast
4.4. Ivf Without Icsi
4.4.1. Key Market Trends Growth Factors, And Opportunities
4.4.2. Market Size And Forecast
4.5. Surrogacy
4.5.1. Key Market Trends, Growth Factors, And Opportunities
4.5.2. Market Size And Forecast
4.6. Others
4.6.1. Key Market Trends, Growth Factors, And Opportunities
4.6.2. Market Size And Forecast

Chapter 5: Fertility Services Market, By Service
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Fresh Non-Donor
5.2.1. Market Size And Forecast
5.3. Frozen Non-Donor
5.3.1. Market Size And Forecast
5.4. Egg & Embryo Banking
5.4.1. Market Size And Forecast
5.5. Fresh Donor
5.5.1. Market Size And Forecast
5.6. Frozen Donor
5.6.1. Market Size And Forecast

Chapter 6: Fertility Services Market, By End User
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Fertility Clinics
6.2.1. Market Size And Forecast
6.3. Hospitals
6.3.1. Market Size And Forecast
6.4. Surgical Centers
6.4.1. Market Size And Forecast
6.5. Clinical Research Institutes
6.5.1. Market Size And Forecast

Chapter 7: Fertility Services Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.3. Market Size And Forecast, By Procedure
7.2.4. Market Size And Forecast, By Service
7.2.5. Market Size And Forecast, By End User
7.2.5.1. U.S. Market Size And Forecast, By Procedure
7.2.5.2. U.S. Market Size And Forecast, By Service
7.2.5.3. U.S. Market Size And Forecast, By End User
7.2.5.4. Canada Size And Forecast, By Procedure
7.2.5.5. Canada Market Size And Forecast, By Service
7.2.5.6. Canada Market Size And Forecast, By End User
7.2.5.7. Mexico Market Size And Forecast, By Procedure
7.2.5.8. Mexico Market Size And Forecast, By Service
7.2.5.9. Mexico Market Size And Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Europe Market Size And Forecast, By Country
7.3.3. Europe Market Size And Forecast, By Procedure
7.3.4. Europe Market Size And Forecast, By Service
7.3.5. Europe Market Size And Forecast, By End User
7.3.5.1. Germany Market Size And Forecast, By Procedure
7.3.5.2. Germany Market Size And Forecast, By Service
7.3.5.3. Germany Market Size And Forecast, By End User
7.3.5.4. France Market Size And Forecast, By Procedure
7.3.5.5. France Market Size And Forecast, By Service
7.3.5.6. France Market Size And Forecast, By End User
7.3.5.7. UK Market Size And Forecast, By Procedure
7.3.5.8. UK Market Size And Forecast, By Service
7.3.5.9. UK Market Size And Forecast, By End User
7.3.5.10. Italy Market Size And Forecast, By Procedure
7.3.5.11. Italy Market Size And Forecast, By Service
7.3.5.12. Italy Market Size And Forecast, By End User
7.3.5.13. Spain Market Size And Forecast, By Procedure
7.3.5.14. Spain Market Size And Forecast, By Service
7.3.5.15. Spain Market Size And Forecast, By End User
7.3.5.16. Russia Market Size And Forecast, By Procedure
7.3.5.17. Russia Market Size And Forecast, By Service
7.3.5.18. Russia Market Size And Forecast, By End User
7.3.5.19. Rest of Europe Market Size And Forecast, By Procedure
7.3.5.20. Rest of Europe Market Size And Forecast, By Service
7.3.5.21. Rest of Europe Market Size And Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.3. Asia-Pacific Market Size And Forecast, By Procedure
7.4.4. Asia-Pacific Market Size And Forecast, By Service
7.4.5. Asia-Pacific Market Size And Forecast, By End User
7.4.5.1. Japan Market Size And Forecast, By Procedure
7.4.5.2. Japan Market Size And Forecast, By Service
7.4.5.3. Japan Market Size And Forecast, By End User
7.4.5.4. India Market Size And Forecast, By Procedure
7.4.5.5. India Market Size And Forecast, By Service
7.4.5.6. India Market Size And Forecast, By End User
7.4.5.7. China Market Size And Forecast, By Procedure
7.4.5.8. China Market Size And Forecast, By Service
7.4.5.9. China Market Size And Forecast, By End User
7.4.5.10. Australia Market Size And Forecast, By Procedure
7.4.5.11. Australia Market Size And Forecast, By Service
7.4.5.12. Australia Market Size And Forecast, By End User
7.4.5.13. South Korea Market Size And Forecast, By Procedure
7.4.5.14. South Korea Market Size And Forecast, By Service
7.4.5.15. South Korea Market Size And Forecast, By End User
7.4.5.16. Rest of Asia-Pacific Market Size And Forecast, By Procedure
7.4.5.17. Rest of Asia-Pacific Market Size And Forecast, By Service
7.4.5.18. Rest of Asia-Pacific Market Size And Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.3. LAMEA Market Size And Forecast, By Procedure
7.5.4. LAMEA Market Size And Forecast, By Service
7.5.5. LAMEA Market Size And Forecast, By End User
7.5.5.1. Latin America Market Size And Forecast, By Procedure
7.5.5.2. Latin America Market Size And Forecast, By Service
7.5.5.3. Latin America Market Size And Forecast, By End User
7.5.5.4. Middle East Market Size And Forecast
7.5.5.5. Middle East Market Size And Forecast, By Service
7.5.5.6. Middle East Market Size And Forecast, By End User
7.5.5.7. Africa Market Size And Forecast
7.5.5.8. Africa Market Size And Forecast, By Service
7.5.5.9. Africa Market Size And Forecast, By End User

Chapter 8: Company Profiles
8.1. Apollo Hospitals Enterprise Ltd.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.1.6. Key Strategic Moves And Developments
8.2. Care Fertility Group Ltd.
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Key Strategic Moves And Developments
8.3. Carolinas Fertility Institute
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.4. City Fertility
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Key Strategic Moves And Developments
8.5. Fertility Associates Limited
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.6. Genea Limited
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Key Strategic Moves And Developments
8.7. Medicover Group (Medicover Fertility And First Egg Bank)
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Business Performance
8.8. Monash Ivf Group Limited
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance
8.8.6. Key Strategic Moves And Developments
8.9. Progyny Inc.
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Key Strategic Moves And Developments
8.10. Virtus Health
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance

*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Medicover Group
  • Monash IVF Group
  • OvaScience Inc.
  • Progyny Inc.
  • Xytex Cryo Internationa
  • MORE
According to the report titled, 'Fertility Services Market by Product and Application: Global Opportunity Analysis and Industry Forecast, 2018-2026,' the global fertility services market size is expected to reach $27,152 million by 2026, registering a CAGR of 8.9% from 2018 to 2026, in terms of value.

The global fertility services market generated $13,655 million in 2018 and is projected to reach $27,151 million by 2026, growing at a CAGR of 8.9% from 2019 to 2026. Asia-Pacific is estimated to be the highest revenue contributor throughout the forecast period.

Fertility services are availed by people who are unable to conceive naturally. These services assist infertile couples, single parents, and LGBT community to procreate and start a family. IVF and other assisted reproductive technology (ART) procedures, surrogacy, and artificial insemination are some of the widely performed fertility services.

The fertility services market growth is driven by increase in infertility rates, rise in trend of delayed pregnancies, surge in ART success rate, and growth in disposable income. Furthermore, rise in prevalence of infertility due to increase in risk factors, such as obesity, stress, polycystic ovarian syndrome (PCOS), sexually transmitted infections, endometrial tuberculosis, and other medical conditions, is expected to offer lucrative opportunities for the fertility services market growth during the forecast period.

Based on procedure, the IVF with ICSI segment accounted for half of the fertility services market share in 2018. This segment is expected to exhibit a prominent growth rate, owing to some key factors such higher success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, low sperm count, and others.

Based on fertility services market trends by end user segment, fertility clinics generated revenue the highest revenue in 2018 and is anticipated to continue the same during the forecast period. The segment of surgical centers would exhibit prominent growth rate due to availability of various fertility procedures under one roof, development of fertility devices with advanced technologies and the availability of a skilled workforce.

Key Findings of the Fertility Services Market:
The IVF with ICSI segment accounted the highest market share of 50% in 2018 and is anticipated to grow at the fastest during the forecast period segment is anticipated to grow at the fastest rate during the forecast period.
The Asia-Pacific region was the major shareholder and accounted for the highest share of 38% in 2018.
Based on service, the egg and embryo banking segment is expected to grow at a CAGR of 11.2 % during the forecast period.
Fresh non-donor segment dominated the market share in 2018 and is anticipated to maintain its dominance during the forecast period.
In addition, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to surge in adoption of fertility procedures, development in the healthcare infrastructure, and rise in fertility tourism.
Note: Product cover images may vary from those shown
5 of 5
  • The Johns Hopkins Health System Corp
  • Medicover Group
  • Monash IVF Group
  • OvaScience Inc.
  • Progyny Inc.
  • Xytex Cryo Internationa
Note: Product cover images may vary from those shown
6 of 5

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll